Seizures Post Intracerebral Hemorrhage

Wolfson Medical Center (WMC)

Status and phase: Completed; Phase 4

Conditions: Post Cerebral Hemorrhage

Treatments: Drug: placebo bid; Drug: valproic acid

Study type: Interventional

Funder types: Other

Identifiers

NCT01115959

001

Details and patient eligibility

About

This study examines early antiepileptic treatment with valproic acid for acute cerebral hemorrhage against a placebo group immediately post event to evaluate the outcome of these patients regarding seizures and neurological outcome.

Enrollment: 72 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• cerebral hemorrhage spontaneous

Exclusion criteria

• early seizures

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

72 participants in 2 patient groups, including a placebo group

valproic acid

Active Comparator group

Description:

Valproic acid given orally 400mg twice daily

Treatment:

Drug: valproic acid

Drug: placebo bid

placebo

Placebo Comparator group

Description:

Placebo twice daily for one month

Treatment:

Drug: placebo bid